Bachleda Mark
CIK 0001887762
Chief Commercial OfficerDirector
Filings
4
Latest Jun 11, 2025
Issuers covered
2
Showing
4 of 4
Page 1
Track record
1 of 1 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 1 | 100% | +28.3% | +28.3% | +28.3% | +28.3% |
| 90 days | 1 | 100% | +49.3% | +49.3% | +49.3% | +49.3% |
| 180 days | 1 | 0% | -91.1% | -91.1% | -91.1% | -91.1% |
| 365 days | 1 | 0% | -90.4% | -90.4% | -90.4% | -90.4% |
Issuers
Companies where Bachleda Mark has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| GRTX | Galera Therapeutics, Inc. | 3 | Mar 20, 2023 |
| LYEL | Lyell Immunopharma, Inc. | 1 | Jun 11, 2025 |
All filings
4 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|